Sector: MedicalMylan Laboratories, Inc. (NYSE: MYL)
Ranking History
Scan Date: | 2/2/2010 |
Sector: | Medical |
Funamental : | 182 |
Technical : | 233 |
Performance : | 163 |
Overall: | 229 |
Number of Stocks: | 309 |
Scan Date: | 1/26/2010 |
Sector: | Medical |
Funamental : | 184 |
Technical : | 247 |
Performance : | 155 |
Overall: | 232 |
Number of Stocks: | 309 |
Scan Date: | 1/19/2010 |
Sector: | Medical |
Funamental : | 183 |
Technical : | 248 |
Performance : | 105 |
Overall: | 205 |
Number of Stocks: | 308 |
Headlines
- Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
Feb 09, 2010 06:39 PM | MYL
- Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
Feb 04, 2010 11:38 AM | MYL
- Mylan Schedules Fourth Quarter 2009 Financial Results Conference Call and Live Webcast
Feb 02, 2010 07:00 AM | MYL
- Mylan Receives Approval for Generic Version of GoLytely(R)
Jan 29, 2010 10:39 AM | MYL
- Mylan Declares Quarterly Preferred Stock Dividend
Jan 20, 2010 02:43 PM | MYL
- Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Jan 11, 2010 07:30 AM | MYL
- Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
Jan 08, 2010 07:30 AM | MYL
- Many Reasons To Launch A Global Generic Drug ETF
Dec 24, 2009 05:49 PM | MYL, NVS, PFE, TEVA, WPI
- Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets
Dec 22, 2009 08:01 AM | MYL
- Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
Dec 22, 2009 07:01 AM | MYL
- UPS, Halliburton, Apollo Group are movers
Jan 08, 2010 06:08 PM | APOL, CMG, CYCC, GS, HAL, MYL
- Nasdaq-100 soon to list Mylan Inc.: Index includes largest securities on market
Dec 17, 2009 04:55 PM | AMZN, CPA, EBAY, MSFT, MYL, SBUX
- Mylan Reports Loss, Beats Estimates
Oct 30, 2009 12:53 PM | MYL, PG
- Mylan Earnings Down but Forecast Raised
Oct 29, 2009 12:54 PM | MYL, PG
- Lang:WVU Still Violates Court Order: Judge Ruled Against Academic Hearing
Sep 23, 2009 07:52 AM | MYL
- Pittsburgh Post-Gazette Week in Review Column
Aug 16, 2009 10:59 AM | END, GM, II, KO, LINE, MYL
- Merck sued over patent on allergy drug Singulair
Aug 14, 2009 04:52 PM | MRK, MYL
- Pittsburgh Post-Gazette Heard Off the Street Column
Aug 02, 2009 06:12 PM | AA, AEO, AG, BK, CNX, CW
- USEC, Interpublic, Office Depot are big movers
Jul 28, 2009 05:18 PM | IPG, MYL, ODP, SPSS, THC, TXT
- Varian, Aetna, Plains Exploration are big movers
Jul 27, 2009 06:13 PM | A, AET, COH, MYL, RSH, VARI
- PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited
Nov 05, 2009 10:52 AM | MYL, NRDS, SU
- Teva Comments on Mylan Paragraph IV Filing for COPAXONE®; Files Lawsuit Against Generic Filer for Patent Infringement
Oct 16, 2009 05:52 PM | MNTA, MYL, TEVA
- Audit Integrity Announces Results of Corporate Bankruptcy Study; Identifies Companies Most Likely to Declare Bankruptcy
Sep 16, 2009 09:51 AM | AIV, AMD, AMKR, AMR, CAL, GT
- Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Aug 27, 2009 08:01 AM | MYL
- Dey Issues Advisory
Aug 19, 2009 11:37 PM | MYL
- Mylan Files Lawsuit Against Pittsburgh Post-Gazette
Aug 19, 2009 09:07 AM | MYL
- Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Aug 18, 2009 11:16 AM | MYL
- Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
Aug 13, 2009 10:39 AM | MYL
- Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)
Aug 10, 2009 03:34 PM | MYL
- President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries
Aug 06, 2009 12:31 PM | MYL
- Form 4 MYLAN INC. For: Jan 31 Filed by: Malik Rajiv (10K)
Feb 02, 2010 05:48 PM
- Form 4 MYLAN INC. For: Dec 11 Filed by: LEECH DOUGLAS J (10K)
Dec 11, 2009 05:37 PM
- Form 4 PARRISH MARK W For: Sep 01 (10K)
Sep 03, 2009 06:08 PM
- Form 3 PARRISH MARK W For: Sep 01 (10K)
Sep 03, 2009 06:08 PM
- Form 4 Varney Jolene L. For: Jun 08 (10K)
Jun 08, 2009 07:41 PM
- Form 3 Varney Jolene L. For: Jun 08 (10K)
Jun 08, 2009 07:34 PM
- Form 4 VANDERVEEN RANDALL L For: May 07 (10K)
May 08, 2009 06:46 PM
- Form 4 TODD C B For: May 07 (10K)
May 08, 2009 06:40 PM
- Form 4 PUSKAR MIKE For: May 07 (10K)
May 08, 2009 06:35 PM
- Form 4 Piatt Rodney L For: May 07 (10K)
May 08, 2009 06:30 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MYL
|
Compare to S&P
|
| YTD |
-2.93 %
|
1.52 %
|
| 4 Weeks |
2.70 %
|
10.29 %
|
| 12 Weeks |
2.00 %
|
4.61 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 39.13 %
|
|
Sales Growth in Last Quarter: -0.23 %
|
|
Sales Growth in Last Quarter: -23.71 %
|
|
